Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03789526|
Recruitment Status : Recruiting
First Posted : December 28, 2018
Last Update Posted : December 28, 2018
|Condition or disease||Intervention/treatment||Phase|
|Ultrasound Guided Injection||Procedure: ultrasound guidance||Not Applicable|
The current study will based on follow up study, conducted among patients presenting at outpatient rheumatology clinics of Al-Azhar University Hospitals, Egypt. with Diabetes mellitus duration at least 3 years and tenosynovitis of hand tendons with Richie tenderness grade 3.
All patients will randomized in two groups: Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance. Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.
The affected tendons will scanned and scored for inflammation using ultrasound in all patients before the triamcinolone injection and then to be reassessed one month after the injection to determine the change in the tendons in both groups.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||52 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||
|Masking:||None (Open Label)|
|Official Title:||Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus|
|Actual Study Start Date :||December 11, 2018|
|Estimated Primary Completion Date :||January 31, 2019|
|Estimated Study Completion Date :||February 1, 2019|
Experimental: Group 1
Procedure: ultrasound guidance
ultrasound guidance of tendon injection
No Intervention: Group 2
Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.
- change in Tenosynovitis pain [ Time Frame: one month ]changes in VAS scale for pain,
- change in Tenosynovitis tenderness [ Time Frame: one month ]changes in Richie index for tenderness.
- changes in ultrasound images of the Tenoasynovitis. [ Time Frame: one month ]changes in Gery scale images, and power Doppler images of the tendons
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03789526
|Contact: Ahmed Abogamal, firstname.lastname@example.org|
|Al-Azhar university hospitals||Recruiting|
|Cairo, Egypt, 11311|
|Contact: Ahmed Abogamal +201001972099 email@example.com|